This round will provide capital for development of its HSC program, including a US Phase I clinical trial in female diffuse hair loss patients and a late-stage HSC trial in male pattern hair loss, expand its manufacturing capability, other corporate purposes and to support preparation for an initial public offering (IPO)
"expand its manufacturing capability and to support preparation for an initial public offering" , like that kind of words
Bookmarks